LOH analysis should not be used as a tool to assess whether UVs of BRCA1/2 are pathogenic or not

Fam Cancer. 2010 Sep;9(3):289-90. doi: 10.1007/s10689-009-9318-9.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Breast Neoplasms / genetics*
  • Female
  • Genes, BRCA1*
  • Genes, BRCA2*
  • Genetic Predisposition to Disease
  • Humans
  • Loss of Heterozygosity*
  • Ovarian Neoplasms / genetics*